financial misappropriation ann is out, page-27

This is better than a Cap raise- wonder how much and when we can claw monies back- POH expects substantial part of the missing funds so put a circle around $4 Mill +. POH could now have $18 Mill in bank plus the $3 Mill from Tax rebate + revenues beginning to flow from the likes of Themis, GNC and a possible upfront from Nippon Zoki if they sign off the Diclo US deal :
"The Company and Nippon Zoki are currently negotiating a licensing arrangement that will include milestone and royalty payments to Phosphagenics on completion of an advanced topical product development. This agreement follows on from a pre-licensing deal announced in March 2012, which enabled Nippon Zoki to test and assess continuously Phosphagenics’ patented TPM®/Diclofenac topical formulation for its suitability as a prescription item in the US and Japanese markets.

My Point is its still business as usual at POH and this Esra business has distracted us from the fact that there is much progressing on multiple clinical and commercial fronts for POH. Now we have additional potential funds to accelerate some programs.

All in all I don't feel so bad today. No one will shed a tear for Esra now the quantum of her fraud has been declared but we still have a very bright future in POH and she does not. Karma